中药注射剂：历经80年发展后的现状
Traditional Chinese medicine injections: where we are after 80-year development.
作者信息
Zheng Wenwen, Wu Yiyang, Gao Hanlu, Ouyang Defang
机构信息
Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China.
出版信息
Chin Med. 2022 Nov 8;17(1):127. doi: 10.1186/s13020-022-00681-w.
Traditional Chinese medicine (TCM) injection is the combination of modern pharmaceutical technology and traditional Chinese prescription, which was born in 1941 and played a great role in the backward medical conditions at that time. However, the debate over TCM injections has never stopped due to adverse drug reactions (ADRs). The regulation on TCM injections has been further strengthened since 2017, which has prompted many TCM injections to carry out re-evaluations on quality, safety, efficiency as well as pharmacoeconomics, which made significant changes and progress. This review presented an up-to-date analysis of the types, amounts, and ADRs of TCM injections based on the published data and literature. This review also summarized the potential reasons for the ADRs and re-evaluation strategies. This review will provide some useful clues for TCM injections and their clinical use.
中药注射剂是现代制药技术与传统中药方剂相结合的产物，诞生于1941年，在当时落后的医疗条件下发挥了巨大作用。然而，由于药物不良反应（ADR），关于中药注射剂的争论从未停止。自2017年以来，对中药注射剂的监管进一步加强，促使许多中药注射剂在质量、安全性、有效性以及药物经济学方面进行重新评估，取得了重大变化和进展。本综述基于已发表的数据和文献，对中药注射剂的类型、数量和不良反应进行了最新分析。本综述还总结了不良反应的潜在原因和重新评估策略。本综述将为中药注射剂及其临床应用提供一些有用的线索。
Zotero 插件